Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RYZB

RayzeBio (RYZB) Stock Price, News & Analysis

RayzeBio logo

About RayzeBio Stock (NASDAQ:RYZB)

Advanced Chart

Key Stats

Today's Range
$62.49
$62.49
50-Day Range
$62.27
$62.49
52-Week Range
$17.95
$62.51
Volume
N/A
Average Volume
553,592 shs
Market Capitalization
$3.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RYZB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RayzeBio and its competitors with MarketBeat's FREE daily newsletter.

RYZB Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Getting In on This "Macro-Trend"
Andreas Halvorsen's Firm Sells Out of RayzeBio Inc
RYZB Aug 2024 35.000 put
RYZB May 2024 55.000 put
See More Headlines

RYZB Stock Analysis - Frequently Asked Questions

RayzeBio (RYZB) raised $311 million in an IPO on Friday, September 15th 2023. The company issued 17,277,600 shares at $18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that RayzeBio investors own include Apogee Therapeutics (APGE), Broadcom (AVGO), Citigroup (C), Citizens Financial Group (CFG), Cisco Systems (CSCO), Fifth Third Bancorp (FITB) and Intel (INTC).

Company Calendar

Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RYZB
CIK
1825367
Fax
N/A
Employees
88
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
31.85
Quick Ratio
31.85

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
59,920,000
Free Float
N/A
Market Cap
$3.74 billion
Optionable
Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:RYZB) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners